• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨密度模型在致癌风险定量评估中的应用

[Application of BMD models in quantitative evaluation of carcinogenic risk].

作者信息

Szymczak W

机构信息

Zakładu Epidemiologii Srodowiskowej, Instytutu Medycyny Pracy im. prof. dra med. Jerzego Nofera w Lodzi.

出版信息

Med Pr. 1998;49(6):579-87.

PMID:10204147
Abstract

The characteristics of the relationship between the exposure level and the incidence of harmful health effects is a general objective of assessing health risk related to chemical exposure. A real dose-response relationship, particularly for low doses, is usually unknown thus it can only be deduced on the basis of biological and statistical considerations. Low dose risk estimation requires extrapolation beyond the range of data observed. Nowadays, quantitative risk assessment encounters certain duality as linear models are mostly used in evaluation of environmental exposure, and nonlinear models are most frequently applied in occupational exposure. Bearing in mind that the assumption on the dose-response linear relationship is an apparent simplification built on our lack of knowledge of carcinogenic mechanisms, it seems that the proposal of the US Environmental Protection Agency (US EPA) to use benchmark dose methods (BMD) for exposure effects manifested by neoplasms, is the compromise between a conservative approach of the EPA towards risk modelling resulting from the limited knowledge of these mechanisms and lack of criteria for selection of nonlinear models. In the case of carcinogenic risk assessment, this solution involves the identification of so called 'cut off point' by applying relevant statistical models. The cut off point indicates the exposure level that contributes to the increase in risk by 10%, 5% or 1%. Another possibility is to use interspecies extrapolation methods for the cut of point modification, and then draw a line between the cut off point and the beginning of the system of co-ordinates. Since it is not feasible to apply a complete BMD methods for certain chemicals (e.g. bezo(a)pirene), not because of chemical properties, but due to insufficient experimental experience, it is proposed to use the method of sticking together a straight line and a curve in relation to a two-grade curve and not to its confidence limitation.

摘要

暴露水平与有害健康影响发生率之间关系的特征是评估与化学物质暴露相关的健康风险的总体目标。真正的剂量-反应关系,尤其是低剂量的关系,通常是未知的,因此只能基于生物学和统计学考量来推断。低剂量风险评估需要在观察到的数据范围之外进行外推。如今,定量风险评估面临一定的二元性,因为线性模型大多用于环境暴露评估,而非线性模型则最常用于职业暴露评估。鉴于剂量-反应线性关系的假设显然是基于我们对致癌机制缺乏了解而做出的简化,美国环境保护局(US EPA)提议对肿瘤表现出的暴露效应使用基准剂量方法(BMD),这似乎是EPA在因对这些机制了解有限以及缺乏非线性模型选择标准而采取的保守风险建模方法之间的一种折衷。在致癌风险评估中,这种解决方案涉及通过应用相关统计模型来确定所谓的“临界点”。临界点表明导致风险增加10%、5%或1%的暴露水平。另一种可能性是使用种间外推方法来修改临界点,然后在临界点与坐标系起点之间画一条线。由于对某些化学物质(如苯并(a)芘)应用完整的BMD方法不可行,不是因为化学性质,而是由于实验经验不足,建议使用将直线和曲线粘合成二级曲线而非其置信区间的方法。

相似文献

1
[Application of BMD models in quantitative evaluation of carcinogenic risk].骨密度模型在致癌风险定量评估中的应用
Med Pr. 1998;49(6):579-87.
2
A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.一种基于剂量描述符T25的非阈值致癌物定量风险评估的简单方法。
Pharmacol Toxicol. 2001 Jun;88(6):331-41.
3
[Quantitative evaluation for risk assessment of neoplasms caused by exposure to chemical substances].[化学物质暴露所致肿瘤风险评估的定量评价]
Med Pr. 2000;51(6):625-36.
4
Regulatory cancer risk assessment based on a quick estimate of a benchmark dose derived from the maximum tolerated dose.基于从最大耐受剂量得出的基准剂量快速估算的监管性癌症风险评估。
Regul Toxicol Pharmacol. 1998 Dec;28(3):222-5. doi: 10.1006/rtph.1998.1258.
5
The benchmark dose method--review of available models, and recommendations for application in health risk assessment.基准剂量法——现有模型综述及在健康风险评估中的应用建议。
Crit Rev Toxicol. 2003;33(5):505-42.
6
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.邻苯二甲酸二(2-乙基己基)酯的癌症风险评估:美国环境保护局新风险评估指南的应用
Regul Toxicol Pharmacol. 1999 Jun;29(3):327-57. doi: 10.1006/rtph.1999.1296.
7
Quantitative approaches to human risk assessment for noncancer health effects.非癌症健康影响的人类风险评估定量方法。
Neurotoxicology. 1990 Summer;11(2):189-98.
8
[Evolution of industrial toxicology toward vanishing doses and the human genome].[工业毒理学向微量剂量与人类基因组的演变]
Med Lav. 2003 Jan-Feb;94(1):69-82.
9
Precision of benchmark dose estimates for continuous (nonquantal) measurements of toxic effects.毒性效应连续(非定量)测量的基准剂量估计精度。
Regul Toxicol Pharmacol. 1996 Aug;24(1 Pt 1):19-23. doi: 10.1006/rtph.1996.0060.
10
[The evaluation of occupational exposure to carcinogenic substances: limit values and risk assessments].[职业接触致癌物质的评估:限值与风险评估]
G Ital Med Lav. 1990 Sep-Nov;12(5-6):201-7.